UK Regulator Approves Eli Lilly's Foundayo Pill for 2 Uses, a First European License
Updated
Updated · POLITICO Europe · Aug 10
UK Regulator Approves Eli Lilly's Foundayo Pill for 2 Uses, a First European License
3 articles · Updated · POLITICO Europe · Aug 10
Summary
Britain's MHRA cleared Foundayo on Monday for both weight management and type 2 diabetes, giving Eli Lilly its first European approval for the oral GLP-1 drug.
The decision puts the UK ahead of the EU, where a ruling on orforglipron is not expected until next year.
Foundayo is Lilly's first pill in the fast-growing GLP-1 class, extending a franchise that already includes injectable Mounjaro.
Demand for GLP-1 treatments has surged as celebrity and influencer backing helped push obesity drugs into the mainstream.